上海医药:终止I001-B(美国)、I022(美国)、C012(美国)项目

格隆汇
Jan 01, 2025

格隆汇1月1日丨上海医药(601607.SH)发布公告,为合理配置研发资源、聚焦优势研发项目,上海医药基于对研发项目未来市场价值、业务协同以及后续开发投入等因素的综合评估,决定终止I001-B(美国)、I022(美国)、C012(美国)这三个研发项目的临床试验及后续开发。其中,I001-B(美国)及I022(美国)处于美国临床试验II期,C012(美国)获得美国食品药品监督管理局(简称“FDA”)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10